Xenter unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem.
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
Excess Equipment Sale for BioUtah Members
FDA Clears World’s First Single-use 5mm Laparoscope with Auto-Focus
Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety
The European Commission’s approval of a novel gene therapy for severe hemophilia A has paved the way for use of a companion diagnostic in the European Union (EU).
Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.
The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation.
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022.
Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336.